I am part of the Edinburgh Palliative and Supportive Care Group (EPaS – Group Lead Professor Marie Fallon) at the Institute of Genetics and Cancer (formerly the IGMM - Institute of Genetics and Molecular Medicine).
Our work has demonstrated that this inflammatory response influences survival and also quality of life in patients with advanced cancer. This understanding provides valuable insight into the genesis of cachexia, fatigue, pain and reduced physical function which in turn can inform potential novel therapeutic targets to address these.